Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
19,800
Employees19,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
19,800
Employees19,800

EW Key Statistics

Market cap
37.59B
Market cap37.59B
Price-Earnings ratio
24.57
Price-Earnings ratio24.57
Dividend yield
Dividend yield
Average volume
8.73M
Average volume8.73M
High today
$63.80
High today$63.80
Low today
$60.00
Low today$60.00
Open price
$61.31
Open price$61.31
Volume
14.11M
Volume14.11M
52 Week high
$96.12
52 Week high$96.12
52 Week low
$58.93
52 Week low$58.93

EW News

Simply Wall St 17h
Calculating The Intrinsic Value Of Edwards Lifesciences Corporation

Key Insights Edwards Lifesciences' estimated fair value is US$71.97 based on 2 Stage Free Cash Flow to Equity With US$59.70 share price, Edwards Lifesciences...

Calculating The Intrinsic Value Of Edwards Lifesciences Corporation
TipRanks 1d
Edwards Lifesciences Plunges 31% after J.P. Morgan and Truist Downgrades

Edwards Lifesciences shares (EW) plummeted about 31% in today’s trading after J.P. Morgan and Truist both downgraded the medical technology company. Indeed, the...

Benzinga 1d
These Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 Results

Edwards Lifesciences Corporation EW reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the compa...

These Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 Results

Analyst ratings

48%

of 33 ratings
Buy
45.5%
Hold
48.5%
Sell
6.1%

More EW News

The Wall Street Journal 1d
S&P 500’s Biggest Loser Has a Heart Valve Problem

Edwards Lifesciences, the largest maker of minimally invasive heart valve replacements, was down 28% on Thursday, the biggest decliner in the S&P 500 index. The...

S&P 500’s Biggest Loser Has a Heart Valve Problem
Investor's Business Daily 2d
Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year

Edwards Lifesciences (EW) stock plunged late Wednesday after the medtech company reported adjusted profit of 70 cents per share on $1.63 billion in second-quart...

Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year
Simply Wall St 4d
Edwards Lifesciences Corporation's Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Edwards Lifesciences (NYSE:EW) has had a rough month with its share price down 3.2%. However, stock prices are usually driven by a company’s financial performan...

Edwards Lifesciences Corporation's Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.